Chapter 1. Research Scope
1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
1.4.1. Market size breakdown, by type
1.4.2. Market size breakdown, by application
1.4.3. Market size breakdown, by end user
1.4.4. Market size breakdown, by region
1.4.5. Market size breakdown, by country
1.5. Market Data Reporting Unit
1.5.1. Value
1.6. Key Stakeholders
Chapter 2. Research Methodology
2.1. Secondary Research
2.1.1. Paid
2.1.2. Unpaid
2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Voice of Industry Experts/KOLs
Chapter 5. Market Indicators
Chapter 6. Industry Outlook
6.1. Market Dynamics
6.1.1. Trends
6.1.2. Drivers
6.1.3. Restraints/challenges
6.1.4. Impact analysis of drivers/restraints
6.2. Impact of COVID-19
6.3. Porter’s Five Forces Analysis
6.3.1. Bargaining power of buyers
6.3.2. Bargaining power of suppliers
6.3.3. Threat of new entrants
6.3.4. Intensity of rivalry
6.3.5. Threat of substitutes
Chapter 7. Global Market
7.1. Overview
7.2. Market Revenue, by Type (2017–2030)
7.3. Market Revenue, by Application (2017–2030)
7.4. Market Revenue, by End user (2017–2030)
7.5. Market Revenue, by Region (2017–2030)
Chapter 8. North America Market
8.1. Overview
8.2. Market Revenue, by Type (2017–2030)
8.3. Market Revenue, by Application (2017–2030)
8.4. Market Revenue, by End user (2017–2030)
8.5. Market Revenue, by Country (2017–2030)
Chapter 9. Europe Market
9.1. Overview
9.2. Market Revenue, by Type (2017–2030)
9.3. Market Revenue, by Application (2017–2030)
9.4. Market Revenue, by End user (2017–2030)
9.5. Market Revenue, by Country (2017–2030)
Chapter 10. APAC Market
10.1. Overview
10.2. Market Revenue, by Type (2017–2030)
10.3. Market Revenue, by Application (2017–2030)
10.4. Market Revenue, by End user (2017–2030)
10.5. Market Revenue, by Country (2017–2030)
Chapter 11. LATAM Market
11.1. Overview
11.2. Market Revenue, by Type (2017–2030)
11.3. Market Revenue, by Application (2017–2030)
11.4. Market Revenue, by End user (2017–2030)
11.5. Market Revenue, by Country (2017–2030)
Chapter 12. MEA Market
12.1. Overview
12.2. Market Revenue, by Type (2017–2030)
12.3. Market Revenue, by Application (2017–2030)
12.4. Market Revenue, by End user (2017–2030)
12.5. Market Revenue, by Country (2017–2030)
Chapter 13. U.S. Market
13.1. Overview
13.2. Market Revenue, by Type (2017–2030)
13.3. Market Revenue, by Application (2017–2030)
13.4. Market Revenue, by End user (2017–2030)
Chapter 14. Canada Market
14.1. Overview
14.2. Market Revenue, by Type (2017–2030)
14.3. Market Revenue, by Application (2017–2030)
14.4. Market Revenue, by End user (2017–2030)
Chapter 15. Germany Market
15.1. Overview
15.2. Market Revenue, by Type (2017–2030)
15.3. Market Revenue, by Application (2017–2030)
15.4. Market Revenue, by End user (2017–2030)
Chapter 16. France Market
16.1. Overview
16.2. Market Revenue, by Type (2017–2030)
16.3. Market Revenue, by Application (2017–2030)
16.4. Market Revenue, by End user (2017–2030)
Chapter 17. U.K. Market
17.1. Overview
17.2. Market Revenue, by Type (2017–2030)
17.3. Market Revenue, by Application (2017–2030)
17.4. Market Revenue, by End user (2017–2030)
Chapter 18. Italy Market
18.1. Overview
18.2. Market Revenue, by Type (2017–2030)
18.3. Market Revenue, by Application (2017–2030)
18.4. Market Revenue, by End user (2017–2030)
Chapter 19. Spain Market
19.1. Overview
19.2. Market Revenue, by Type (2017–2030)
19.3. Market Revenue, by Application (2017–2030)
19.4. Market Revenue, by End user (2017–2030)
Chapter 20. Japan Market
20.1. Overview
20.2. Market Revenue, by Type (2017–2030)
20.3. Market Revenue, by Application (2017–2030)
20.4. Market Revenue, by End user (2017–2030)
Chapter 21. China Market
21.1. Overview
21.2. Market Revenue, by Type (2017–2030)
21.3. Market Revenue, by Application (2017–2030)
21.4. Market Revenue, by End user (2017–2030)
Chapter 22. India Market
22.1. Overview
22.2. Market Revenue, by Type (2017–2030)
22.3. Market Revenue, by Application (2017–2030)
22.4. Market Revenue, by End user (2017–2030)
Chapter 23. Australia Market
23.1. Overview
23.2. Market Revenue, by Type (2017–2030)
23.3. Market Revenue, by Application (2017–2030)
23.4. Market Revenue, by End user (2017–2030)
Chapter 24. South Korea Market
24.1. Overview
24.2. Market Revenue, by Type (2017–2030)
24.3. Market Revenue, by Application (2017–2030)
24.4. Market Revenue, by End user (2017–2030)
Chapter 25. Brazil Market
25.1. Overview
25.2. Market Revenue, by Type (2017–2030)
25.3. Market Revenue, by Application (2017–2030)
25.4. Market Revenue, by End user (2017–2030)
Chapter 26. Mexico Market
26.1. Overview
26.2. Market Revenue, by Type (2017–2030)
26.3. Market Revenue, by Application (2017–2030)
26.4. Market Revenue, by End user (2017–2030)
Chapter 27. Saudi Arabia Market
27.1. Overview
27.2. Market Revenue, by Type (2017–2030)
27.3. Market Revenue, by Application (2017–2030)
27.4. Market Revenue, by End user (2017–2030)
Chapter 28. South Africa Market
28.1. Overview
28.2. Market Revenue, by Type (2017–2030)
28.3. Market Revenue, by Application (2017–2030)
28.4. Market Revenue, by End user (2017–2030)
Chapter 29. U.A.E. Market
29.1. Overview
29.2. Market Revenue, by Type (2017–2030)
29.3. Market Revenue, by Application (2017–2030)
29.4. Market Revenue, by End user (2017–2030)
Chapter 30. Competitive Landscape
30.1. List of Market Players and their Offerings
30.2. Competitive Benchmarking of Key Players
30.3. Product Benchmarking of Key Players
30.4. Recent Strategic Developments
Chapter 31. Company Profiles
31.1. MIMEDX Group, Inc
31.1.1. Business overview
31.1.2. Product and service offerings
31.1.3. Key financial summary
31.2. VIVEX Biologics, Inc
31.2.1. Business overview
31.2.2. Product and service offerings
31.3. Organogenesis Holdings Inc
31.3.1. Business overview
31.3.2. Product and service offerings
31.3.3. Key financial summary
31.4. Integra Lifesciences Holdings Corporation
31.4.1. Business overview
31.4.2. Product and service offerings
31.4.3. Key financial summary
31.5. Stryker Corporation
31.5.1. Business overview
31.5.2. Product and service offerings
31.5.3. Key financial summary
31.6. Applied Biologics
31.6.1. Business overview
31.6.2. Product and service offerings
31.7. Celularity Inc
31.7.1. Business overview
31.7.2. Product and service offerings
31.7.3. Key financial summary
31.8. Skye Biologics Holdings, LLC
31.8.1. Business overview
31.8.2. Product and service offerings
31.9. Lucina BioSciences, LLC
31.9.1. Business overview
31.9.2. Product and service offerings
31.10. Next Biosciences
31.10.1. Business overview
31.10.2. Product and service offerings
31.11. TissueTech, Inc
31.11.1. Business overview
31.11.2. Product and service offerings
31.11.3. Key financial summary
31.12. Corza Ophthalmology
31.12.1. Business overview
31.12.2. Product and service offerings
31.13. Merakris Therapeutics, Inc
31.13.1. Business overview
31.13.2. Product and service offerings
31.14. Ventris Medical, LLC
31.14.1. Business overview
31.14.2. Product and service offerings
31.15. Tides Medical
31.15.1. Business overview
31.15.2. Product and service offerings
Chapter 32. Appendix
32.1. Abbreviations
32.2. Sources and References
32.3. Related Reports
| ※参考情報 羊膜製品とは、羊の子宮内にある羊膜から得られる素材を利用した製品を指します。羊膜は胎児を保護し、支持する重要な役割を果たしている膜であり、その成分は主に水分、タンパク質、脂質などで構成されています。羊膜製品はその生物学的特性から、医療や美容、再生医療など多岐にわたる分野で注目されています。 羊膜製品にはいくつかの種類があります。まず医療用羊膜製品が挙げられます。これには、外科手術や創傷治癒に使用される羊膜の移植片があります。羊膜は抗炎症作用や創傷治癒促進作用があるため、特に難治性の潰瘍ややけど、外傷の治癒を助けるのに効果的です。 次に、再生医療における羊膜製品です。羊膜は細胞再生を助ける特性があり、皮膚や眼科の分野で使用されます。例えば、角膜の再生や皮膚の移植において、羊膜が細胞の成長を促進し、傷の治癒を助ける役割を果たします。 美容分野でも羊膜製品は利用されています。羊膜の成分には成長因子が含まれ、それが皮膚の再生を促進するとされているため、アンチエイジングや美容治療に活用されます。特に、羊膜を用いた美容注射やフェイシャルトリートメントが流行しており、肌のハリや弾力を取り戻す効果が期待されています。 さらに、羊膜由来の素材は、バイオマテリアルとしても利用されています。これらは、組織工学や装具、義肢の分野で応用され、動物由来の材料を用いない選択肢として注目されています。 羊膜製品の製造には、さまざまな関連技術が関与しています。まず、羊膜を採取するプロセスでは、高度な清浄技術や無菌加工が重要です。採取後、羊膜は適切に処理され、冷凍保存や乾燥などの方法で保管されます。 また、羊膜の成分を解析し、その生物活性を確認するための研究開発も行われています。成長因子やサイトカインなど、羊膜内に含まれる成分の調査が進んでおり、これにより新たな治療法や製品が創出される可能性があります。 羊膜製品はまた、倫理的な観点からも議論されています。羊膜は主に家畜から得られるものであるため、その取り扱いには十分な配慮が必要です。動物福祉や環境への影響についても問題視されることがありますが、適切に管理された生産プロセスを採用することでこれらの課題を克服することが求められています。 さらに、羊膜製品の研究は急速に進展しており、新しい用途や製品が次々と開発されています。生体適合性を持つ羊膜を利用した新しい治療法や、より効果的で安全な美容製品が市場に登場することが期待されています。 現在では、羊膜製品の市場は急成長を遂げており、さまざまな医療機関や美容クリニックで取り入れられるようになっています。患者や消費者にとっても、羊膜を利用した治療や美容施術は選択肢の一つとして浸透してきています。 羊膜製品は、医療、美容、再生医療など多方面での利用が進み、その効果が実証されつつあります。今後の研究開発によって、さらなる可能性が広がることでしょう。羊膜製品は、私たちの生活の質を向上させるための大きな役割を果たすことが期待されています。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
